Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
M's Science Corporation
Further study details as provided by M's Science Corporation:
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female between the ages of 18 and 65 (inclusive)
Diagnosis of MDD according to the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV criteria and a shortened MINI evaluation
HAM-D17 score of \>/= 21 and a severity score of at least 2 for Item 1 (depressed mood) at both Screening and Baseline
Current depressive episode of at least 3 months duration, and significant depressed mood and anhedonia in the 4 weeks prior to Screening.
You may not be if
Subjects who have received fluoxetine within 1 month prior to Baseline or any other antidepressant within 2 weeks prior to Baseline, or any unlicensed medication within 1 month before Screening
Subjects who require psychotropic medication other than the study medication
Subjects who started psychotherapy within 4 months prior to Screening
Subjects who currently (i.e., in the month prior to Screening) meet DSM-IV criteria for bipolar syndrome or psychotic depression or severe somatoform or eating disorders
Subjects who have a primary diagnosis of anxiety
Subjects who regularly use sleeping medication more than 3 times per week
Subjects who have major psychiatric or neurologic disorders other than MDD
Subjects with depression secondary to stroke, cancer, or other severe medical illness
Subjects who have a history of alcohol or substance dependence(within 1 year prior to Screening)
Clareo Health | SA4503 8-Week Study in Major Depressive Disorder (MDD)
